ACTG ACACIA RESEARCH CORP
Patent Owners & Lessors · Nasdaq · SEC CIK 934549 · Fiscal year ends 12/31
Financial factors as of 2026-09-30 (2026Q3), TTM = sum of the last four quarters
Growth
TTM revenue YoY-3.7%
TTM net income YoY-468.9%
TTM EPS YoY-416.7%
Revenue 3-yr CAGR81.2%
Net income 3-yr CAGR—
Margins
Gross margin23.2%
Operating margin-6.0%
Net margin-6.5%
FCF margin—
EBITDA margin5.7%
Returns
ROE-3.4%
ROA-2.4%
ROIC (approx.)-4.9%
Asset turnover0.36x
Leverage & solvency
Liabilities / assets26.1%
Debt / equity0.21x
Current ratio5.64x
Interest coverage-2.17x
Cash quality & payout
Operating cash flow / net income-1.99x
Accruals ratio-7.0%
Payout ratio—
Capex / revenue—
Factor history charts and full statement history on Pro 🔒
Financial statements
| Line item | FY20252025-12-31 | FY20242024-12-31 | FY20232023-12-31 | FY20222022-12-31 | FY20212021-12-31 |
|---|---|---|---|---|---|
| Income statement | |||||
| Revenue | $285.23M | $122.31M | $125.10M | $59.22M | $88.05M |
| Cost of revenue | $200.75M | $92.66M | $52.83M | $37.39M | $36.10M |
| Gross profit | $84.48M | $29.65M | $72.27M | $21.84M | $51.95M |
| R&D expense | — | — | $735,000 | $626,000 | $200,000 |
| SG&A expense | $65.12M | $55.36M | $44.43M | $52.68M | $35.67M |
| Operating income | $6.41M | -$32.93M | $20.94M | -$40.09M | $14.54M |
| Interest expense | $8.99M | $6.46M | $2.06M | $6.43M | $7.92M |
| Pretax income | $31.31M | -$38.15M | $67.43M | -$127.15M | $174.65M |
| Income tax | $6.84M | -$3.45M | -$1.50M | -$16.21M | $24.29M |
| Net income | $21.68M | -$36.06M | $67.06M | -$125.06M | $149.20M |
| EBITDA | $49.76M | $648,000 | $35.66M | -$26.58M | $25.23M |
| EPS (basic) | 0.23 | -0.36 | 0.73 | -3.13 | 2.43 |
| EPS (diluted) | 0.22 | -0.36 | 0.58 | -3.13 | 1.91 |
| Weighted avg. shares (diluted) | 97.16M | 99.21M | 92.41M | 42.46M | 98.47M |
| Balance sheet | |||||
| Cash & equivalents | $306.72M | $273.88M | $340.09M | $287.79M | $309.36M |
| Short-term investments | — | — | $99.82M | $98.36M | $398.53M |
| Receivables | $26.16M | $26.91M | $80.56M | $8.23M | $9.52M |
| Inventory | $26.56M | $27.48M | $10.92M | $14.22M | $8.93M |
| Current assets | $450.09M | $420.15M | $554.51M | $427.99M | $730.68M |
| PP&E, net | $21.29M | $23.86M | $2.36M | $3.54M | $4.18M |
| Goodwill | $25.79M | $29.34M | $8.99M | $7.54M | $7.47M |
| Intangibles | $48.15M | $55.43M | $33.56M | $36.66M | $48.79M |
| Total assets | $770.96M | $756.39M | $633.54M | $482.93M | $798.86M |
| Current liabilities | $49.04M | $49.64M | $27.64M | $87.21M | $200.19M |
| Short-term debt | $0 | $2.40M | — | — | — |
| Long-term debt | $91.90M | — | — | — | — |
| Total debt | $91.90M | — | — | — | — |
| Total liabilities | $186.92M | $203.78M | $43.94M | $193.68M | $353.63M |
| Shareholders' equity | $543.45M | $514.83M | $568.27M | $258.28M | $419.43M |
| Net debt | -$214.82M | — | — | — | — |
| Shares outstanding | 96.48M | 96.05M | 99.90M | 43.48M | 48.81M |
| Cash flow statement | |||||
| Operating cash flow | $75.24M | $50.12M | -$22.51M | -$37.34M | $13.33M |
| Capital expenditure | — | $148.67M | $189,000 | $732,000 | $91,000 |
| Free cash flow | — | -$98.55M | -$22.70M | -$38.07M | $13.23M |
| Investing cash flow | -$21.01M | -$212.96M | $16.18M | $184.46M | $35.75M |
| Financing cash flow | -$22.73M | $97.56M | $58.63M | -$166.14M | $59.74M |
| Depreciation & amortization | $43.35M | $33.57M | $14.73M | $13.51M | $10.69M |
| Stock-based compensation | $5.74M | $4.79M | $3.30M | $3.82M | $2.05M |
| Dividends paid | — | $0 | $1.40M | $2.80M | $1.45M |
| Share buybacks | $0 | $20.29M | $0 | $50.99M | $4.01M |
Free plan shows the latest 5 periods; Pro shows all 17 🔒
· Financial companies (banks, insurers, …) usually do not report gross profit or operating income; bank revenue is net revenue (net interest income + noninterest income), smaller than "gross interest income + noninterest income".
· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.
Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-18 06:30.